Nebilet Plus H (Hydrochlorothiazide, Nebivolol)

Nebivolol blocks β1‑adrenergic receptors, decreasing heart rate and contractility while promoting nitric‑oxide‑mediated vessel relaxation. Hydrochlorothiazide acts on the kidney’s distal tubule to inhibit sodium‑chloride reabsorption, increasing urine output and lowering plasma volume, together producing a blood‑pressure‑lowering effect.

The dosage of Nebilet Plus H is individualized. A qualified prescriber determines the appropriate strength and frequency based on the patient’s blood‑pressure readings, overall health, and response to therapy.

Nebilet Plus H should be used during pregnancy or lactation only if the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers typically evaluate alternative options before prescribing this combination to pregnant or nursing women.

To request Nebilet Plus H, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nebilet Plus H combines a selective β1‑blocker with a thiazide diuretic, offering dual mechanisms in a single tablet. Compared with monotherapy agents, it can provide more consistent blood‑pressure control and may reduce pill burden, though individual response and tolerance vary among patients.

Store Nebilet Plus H at ambient temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, direct sunlight and heat sources to maintain product stability.

Nebilet Plus H is taken orally, usually once daily as directed by a healthcare professional. Tablets should be swallowed whole with a glass of water, and the dose should be taken at the same time each day to maintain consistent blood‑pressure control.

Serious risks include severe hypotension, acute kidney injury, significant electrolyte imbalances such as hyperkalemia or hyponatremia, and rare allergic reactions. Patients should be monitored for symptoms like faintness, rapid weight change, muscle cramps or swelling and seek medical attention promptly if they occur.

Nebilet Plus H is contraindicated in patients with known hypersensitivity to either component, severe renal impairment, uncontrolled heart failure, or those taking certain interacting medications such as potent CYP2D6 inhibitors without medical supervision.